Pharma Journalist - Page 99 of 937 -

Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy

Lonza Secures Nona’s BBB Technology for CNS Drug Development

Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment

FDA Grants Full Approval of Deciphera’s ROMVIMZA for TGCT Treatment

FDA Approves GSK’s Penmenvy 5-in-1 Meningococcal Vaccine for MenABCWY Protection

QIAGEN Expands Bioinformatics Leadership with New Data Center in Australia/APAC

Newleos Therapeutics Raises $93.5M in Oversubscribed Series A to Advance Neuropsychiatric Disorder Treatments

Nemluvio Approved in EU for Atopic Dermatitis and Prurigo Nodularis

MaxCyte Signs Platform License with TG Therapeutics for Autoimmune Cell Therapies

Health Canada Approves Merck’s KEYTRUDA for Resectable NSCLC with Chemotherapy

Lundbeck’s Amlenetug for MSA Receives FDA Fast Track Designation

AbbVie and Xilio Therapeutics Partner to Develop Tumor-Activated Immunotherapies

Boehringer’s Nerandomilast Hits Primary Endpoint in Phase III FIBRONEER-ILD for Pulmonary Fibrosis